CN103003693B - 青光眼的诊断方法 - Google Patents

青光眼的诊断方法 Download PDF

Info

Publication number
CN103003693B
CN103003693B CN201180028608.XA CN201180028608A CN103003693B CN 103003693 B CN103003693 B CN 103003693B CN 201180028608 A CN201180028608 A CN 201180028608A CN 103003693 B CN103003693 B CN 103003693B
Authority
CN
China
Prior art keywords
glaucoma
antigen
crystallin
protein
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180028608.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103003693A (zh
Inventor
F·格拉斯
N·勃姆
N·菲弗尔
K·贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
M Lab AG
Original Assignee
M Lab AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Lab AG filed Critical M Lab AG
Publication of CN103003693A publication Critical patent/CN103003693A/zh
Application granted granted Critical
Publication of CN103003693B publication Critical patent/CN103003693B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/168—Glaucoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201180028608.XA 2010-04-13 2011-04-13 青光眼的诊断方法 Active CN103003693B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34236310P 2010-04-13 2010-04-13
US61/342,363 2010-04-13
US61/342363 2010-04-13
PCT/CH2011/000077 WO2011127616A1 (en) 2010-04-13 2011-04-13 Diagnostic methods for glaucoma

Publications (2)

Publication Number Publication Date
CN103003693A CN103003693A (zh) 2013-03-27
CN103003693B true CN103003693B (zh) 2016-07-06

Family

ID=43984128

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180028608.XA Active CN103003693B (zh) 2010-04-13 2011-04-13 青光眼的诊断方法

Country Status (17)

Country Link
US (1) US10175251B2 (https=)
EP (1) EP2558862B1 (https=)
JP (2) JP2013529292A (https=)
KR (1) KR101903193B1 (https=)
CN (1) CN103003693B (https=)
AU (1) AU2011241402B2 (https=)
BR (1) BR112012026219B1 (https=)
CA (1) CA2795270C (https=)
DK (1) DK2558862T3 (https=)
ES (1) ES2712060T3 (https=)
HR (1) HRP20190278T1 (https=)
HU (1) HUE042703T2 (https=)
PL (1) PL2558862T3 (https=)
RU (1) RU2657515C2 (https=)
TR (1) TR201902542T4 (https=)
WO (1) WO2011127616A1 (https=)
ZA (1) ZA201207935B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012118863A1 (en) * 2011-02-28 2012-09-07 The Schepens Eye Research Institute, Inc. Therapies that target autoimmunity for treating glaucoma and optic neuropathy
US10842849B2 (en) 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
WO2013126465A1 (en) * 2012-02-21 2013-08-29 MEDEIROS, Felipe, A. Systems and methods for determining retinal ganglion cell populations and associated treatments
EP2770326B1 (en) * 2013-02-26 2019-09-11 Instituto Oftalmologico Fernandez - Vega, S.L. Method for the diagnosis of glaucoma based on the determination of serum protein levels
WO2016060917A2 (en) * 2014-10-15 2016-04-21 Rapid Pathogen Screening, Inc. Formulations for histatin therapeutics
JP6499918B2 (ja) 2015-05-20 2019-04-10 株式会社トプコン 眼科検査支援システム及び眼科検査支援サーバ
RU2617066C1 (ru) * 2016-04-01 2017-04-19 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ определения показаний к интравитреальному введению цилиарного нейротрофического фактора при лечении заболеваний зрительно-нервного аппарата глаза
CN110213987A (zh) 2016-12-05 2019-09-06 杰克逊实验室 视网膜和视神经中的脂肪滴作为人类的神经变性和青光眼的诊断标志物
JP7202609B2 (ja) * 2017-12-13 2023-01-12 国立大学法人東北大学 視神経障害の診断用バイオマーカー
CN108229545B (zh) * 2017-12-22 2021-09-14 北京市商汤科技开发有限公司 青光眼诊断的方法、装置及电子设备
US20220143139A1 (en) * 2019-03-04 2022-05-12 The Schepens Eye Research Institute, Inc. Modulating Neuroinflammation
CN111856037B (zh) * 2020-07-31 2021-06-22 四川大学华西第二医院 Unc45a与hsp10的比值在pop早期预警、诊断、预后评估中的应用和产品
KR102596340B1 (ko) 2020-08-25 2023-11-02 사회복지법인 삼성생명공익재단 안질환 시야 손상 예후 예측 시스템 및 방법과 이를 위한 컴퓨터 프로그램
CN113444789A (zh) * 2021-08-27 2021-09-28 中国医学科学院北京协和医院 青光眼相关生物标志物及其应用
CN114965664A (zh) * 2022-03-21 2022-08-30 上海交通大学 一种获取泪液代谢指纹谱图的方法及筛选方法
CN118425510B (zh) * 2024-05-17 2024-11-19 上海市第一人民医院 一种青光眼诊断的生物标志物及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090105357A (ko) * 2008-04-02 2009-10-07 (주)루미아이제네틱스 녹내장 진단용 키트
CN101563081A (zh) * 2006-12-22 2009-10-21 爱尔康公司 血清淀粉样蛋白a基因在诊断和治疗青光眼以及在鉴定抗青光眼物质中的用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419267D0 (en) 1994-09-23 1994-11-09 Unilever Plc Assay devices
RU2187983C2 (ru) 1998-11-10 2002-08-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ диагностики характера течения глаукомы
US20030149997A1 (en) 1999-02-19 2003-08-07 Hageman Gregory S. Diagnostics and therapeutics for arterial wall disruptive disorders
US20020102581A1 (en) * 1999-02-19 2002-08-01 Hageman Gregory S. Diagnostics and therapeutics for ocular disorders
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
AU2001261103B2 (en) * 2000-04-29 2007-08-23 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
CN1393470A (zh) * 2001-06-29 2003-01-29 上海博德基因开发有限公司 一种多肽——beta转导素－45.65和编码这种多肽的多核苷酸
WO2003049773A1 (en) * 2001-12-11 2003-06-19 Fibrogen, Inc. Methods for inhibiting ocular processes
JP2006506970A (ja) * 2002-07-12 2006-03-02 ユニバーシティ オブ ワシントン 神経細胞の延長されたインビトロ培養のための方法および系
US20060166268A1 (en) * 2002-10-18 2006-07-27 Rescom Gmbh Diagnosis of glaucoma by complex autoantibody repertoires in body fluids
US7442720B2 (en) 2003-12-19 2008-10-28 Omega Bio-Pharma (I.P.3) Limited Compositions and methods for treating diabetes
AU2006272497B2 (en) * 2005-07-27 2012-07-19 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof
EP1832600A1 (en) 2006-03-09 2007-09-12 Max-Delbrück-Centrum Für Molekulare Medizin Peptides against autoantibodies associated with glaucoma and use of these peptides
RU2314535C1 (ru) 2006-07-05 2008-01-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" Способ диагностики начальной стадии открытоугольной глаукомы
KR20090034961A (ko) * 2006-07-08 2009-04-08 유니버시티 오브 켄터키 리서치 파운데이션 폐암 진단 검사
EP1929937A1 (de) 2006-12-07 2008-06-11 F. Hoffmann-Roche AG Vorrichtung und Verfahren zum Untersuchen von Körperflüssigkeiten
RU2371721C2 (ru) 2007-06-25 2009-10-27 Закрытое акционерное общество "Молекулярно-медицинские технологии" Устройство для диагностики с использованием биочипов
GB0724412D0 (en) * 2007-12-14 2008-02-06 Ucl Business Plc Marker
EP2354792A1 (en) 2010-02-08 2011-08-10 Biomonitor A/S Method for detecting anti-drug antibodies
KR20100087276A (ko) 2010-07-21 2010-08-04 (주)루미아이제네틱스 녹내장 진단용 키트
KR20100087275A (ko) 2010-07-21 2010-08-04 (주)루미아이제네틱스 녹내장 진단용 키트

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101563081A (zh) * 2006-12-22 2009-10-21 爱尔康公司 血清淀粉样蛋白a基因在诊断和治疗青光眼以及在鉴定抗青光眼物质中的用途
KR20090105357A (ko) * 2008-04-02 2009-10-07 (주)루미아이제네틱스 녹내장 진단용 키트

Also Published As

Publication number Publication date
KR20130122706A (ko) 2013-11-08
DK2558862T3 (en) 2019-03-18
JP6225157B2 (ja) 2017-11-01
US20130172204A1 (en) 2013-07-04
RU2012147551A (ru) 2014-05-20
BR112012026219A2 (pt) 2016-07-12
AU2011241402A1 (en) 2012-11-15
BR112012026219B1 (pt) 2019-12-10
EP2558862B1 (en) 2018-11-21
ES2712060T3 (es) 2019-05-09
JP2013529292A (ja) 2013-07-18
PL2558862T3 (pl) 2019-07-31
CN103003693A (zh) 2013-03-27
CA2795270A1 (en) 2011-10-20
ZA201207935B (en) 2019-07-31
EP2558862A1 (en) 2013-02-20
KR101903193B1 (ko) 2018-10-01
JP2016048265A (ja) 2016-04-07
TR201902542T4 (tr) 2019-03-21
AU2011241402B2 (en) 2016-09-15
WO2011127616A1 (en) 2011-10-20
HUE042703T2 (hu) 2019-07-29
US10175251B2 (en) 2019-01-08
HRP20190278T1 (hr) 2019-04-19
RU2657515C2 (ru) 2018-06-14
CA2795270C (en) 2021-06-08

Similar Documents

Publication Publication Date Title
CN103003693B (zh) 青光眼的诊断方法
Beutgen et al. Autoantibody biomarker discovery in primary open angle glaucoma using serological proteome analysis (SERPA)
Tezel et al. An astrocyte-specific proteomic approach toInflammatory responses in experimental rat glaucoma
JP5011410B2 (ja) 生体液のプロテオーム分析
JP6170071B2 (ja) Ｃｎｓ損傷についてのバイオマーカーとしての自然免疫タンパク質
Basagaña et al. Allergy to human seminal fluid: cross-reactivity with dog dander
JP2006524331A5 (https=)
JP2013529292A5 (https=)
Tezel et al. Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma
Soria et al. The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE
US11187708B2 (en) Early stage Parkinson's disease diagnostic kits and methods
DK2444814T5 (en) Biomarker for mental disorders, including cognitive disorders, and method of using the biomarker for detecting mental disorders, including cognitive disorders
CN115398239A (zh) 帕金森氏病诊断用生物标记物及利用其的帕金森氏病诊断方法
EP3423835B1 (en) Predictive markers useful in the treatment of wet age-related macular degeneration
EP2603797B1 (en) Method for the diagnosis of dry eye and blepharitis
WO2012004276A2 (en) Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits
CN107449914A (zh) 泛素羧基端酯酶l1自身抗体的应用
Havlik et al. Vitreous proteomics in rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
KR20100087275A (ko) 녹내장 진단용 키트
KR20100087276A (ko) 녹내장 진단용 키트
TW202111324A (zh) Lama2, plxdc2 及 mll4 作為糖尿病前期和糖尿病的新型生物標記
Rogers Biomarkers of Optic Nerve Head Glial Cell Activation Following Biomechanical Insult
HK1122842A (en) Atopic dermatitis marker and technique of using the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20160513

Address after: Germany Mainz

Applicant after: M-LAB AG

Address before: Swiss hole

Applicant before: M-LAB AG

C14 Grant of patent or utility model
GR01 Patent grant